GHB (gamma-hydroxybutyric acid) is a central nervous system depressant that, when used regularly, creates rapid physical dependence. Stopping novel psychoactive substances like GHB abruptly triggers a withdrawal syndrome that ranges from deeply uncomfortable to life-threatening.

This page covers the key facts about GHB withdrawal, including what symptoms to expect, how the timeline unfolds, and what medical detox looks like in practice.

GHB Withdrawal Symptoms

GHB acts on GABA receptors in the brain, similar to alcohol and benzodiazepines [1]. This shared mechanism as a GABA B receptor agonist explains why withdrawal from GHB closely resembles alcohol withdrawal, and why it carries the same potential for serious, sometimes fatal, medical complications [2].

When someone who has been using the substance heavily stops or sharply reduces GHB administration, symptoms typically emerge within 6 to 24 hours of the last use. Early symptoms are largely physical: tremors, sweating, nausea, vomiting, rapid heart rate, and elevated blood pressure. Headache, poor appetite, and diarrhea are also common early signs.

As withdrawal progresses, psychological symptoms emerge and intensify. Anxiety can become severe. Insomnia sets in quickly, often compounded by the sleep disruption that accompanies GHB intoxication itself. In more serious cases, individuals experience hallucinations, extreme confusion, paranoia, and delirium [3]. These symptoms can mimic stimulant intoxication or psychosis, which sometimes leads to misdiagnosis if providers aren’t aware of the person’s GHB use history.

The most severe withdrawal symptoms of GHB include:

• Seizures.

• Rapid onset delirium with agitation, auditory hallucinations, visual hallucinations, and psychosis.

• Rhabdomyolysis (muscle breakdown that releases toxins into the bloodstream).

• Renal failure secondary to rhabdomyolysis.

Rhabdomyolysis is associated with roughly 7% of GHB withdrawal cases, particularly among people who were using GHB as a dietary supplement [4]. When skeletal muscle breaks down rapidly, the released proteins overwhelm the kidneys, potentially causing failure. In rare cases, this proves fatal. More commonly, it results in acute and chronic harms, from physical weakness to significant muscle loss. Prompt medical recognition and aggressive hydration are essential when rhabdomyolysis is suspected during the withdrawal process.

Wernicke-Korsakoff syndrome, a severe neurological condition associated with thiamine deficiency, has also been documented in cases of GHB abuse and withdrawal syndrome [5].

GHB Withdrawal Timeline

How long GHB withdrawal lasts depends heavily on how much a person was using, how often, and for how long. Mild withdrawal from GHB typically resolves within 5 days. Severe gamma-hydroxybutyrate withdrawal can stretch to 2 weeks or longer.

• Hours 6 to 24 – Symptoms of GHB withdrawal begin. Tremors, sweating, nausea, and anxiety are the first to appear. Heart rate and blood pressure start climbing. This window is critical because many people, desperate to stop the discomfort, return to using GHB, which significantly raises overdose risk as tolerance has already dropped.

• Days 1 to 3 – Peak acute withdrawal. Symptoms intensify across the board. In severe cases, hallucinations and delirium emerge around days 2 to 3. Agitated delirium, in particular, can be dangerous and may require intensive care monitoring.

• Days 4 to 5 – Cognitive and sleep disruption become prominent. Altered thinking, disorientation, and sleep deprivation compound each other. This stage can look similar to delirium tremens, the condition seen in severe alcohol withdrawal, which includes psychosis, uncontrollable shaking, and seizure activity.

• Days 6 to 14 – Most acute symptoms subside, but cravings, fatigue, anxiety, and mood instability can linger for several more days.

Some individuals who used GHB heavily for extended periods go on to develop PAWS (post-acute withdrawal syndrome), which involves persistent symptoms well beyond the initial detox window [6]. Reported long-term effects include:

• Neurological damage to the hands or fingers, causing tremors, numbness, or tingling.

• Persistent difficulty with memory and clear thinking.

• Triggered mood disorders, including depression and anxiety.

• Occasional cravings, especially during stress.

The GHB withdrawal timeline illustrates why attempting withdrawal from GHB at home is dangerous. Without medical oversight, escalating symptoms can turn life-threatening before anyone recognizes the severity. GHB has a short half-life [7], meaning it’s rapidly metabolized and withdrawal symptoms arrive fast and early, and the window between manageable discomfort and serious medical crisis is narrow. People who use GHB frequently throughout the day face an especially abrupt onset because they’re essentially in a constant cycle of dosing to prevent withdrawal from the previous dose.

Treatment Medications for GHB Withdrawal

There is no universally standardized pharmacological protocol for GHB withdrawal treatment, and clinical practice varies across drug alcohol dependence facilities and regions. However, several medication classes have demonstrated effectiveness in managing withdrawal symptoms and preventing dangerous complications.

Benzodiazepines are the most widely used first-line treatment. Long-acting benzodiazepines, particularly diazepam (Valium), help suppress the nervous system hyperactivity driving GHB withdrawal without triggering respiratory depression. Doses are typically tapered progressively across the detox period. A common outpatient schedule starts with diazepam 10mg every 6 hours for the first 2 days, then gradually reduces through day 7. In hospital settings, dose requirements can be significantly higher, and some patients require more than 120mg in the first 24 hours, at which point intensive care consultation is warranted. Resistance to benzodiazepine therapy is a recognized complication, particularly after chronic use at very high doses.

Lorazepam may be substituted for patients with severe liver disease, respiratory conditions like COPD, or in elderly populations who metabolize diazepam poorly.

Other medications like barbiturates serve as a second-line option when benzodiazepines fail to control symptoms adequately. Phenobarbitone, in particular, is used in severe withdrawal cases that prove resistant to standard benzodiazepine dosing.

Anticonvulsants help manage seizure risk, which peaks during acute withdrawal.

Antipsychotic medications address hallucinations and agitated delirium when psychological clinical effects dominate the picture.

All medications used in GHB withdrawal management carry meaningful risks, particularly when combined with opioids or other CNS depressants. This is a key reason why GHB detox should never be attempted without professional medical oversight.

Medications work best alongside behavioral therapy. GHB withdrawal treatment that combines pharmacological stabilization with evidence-based therapeutic approaches, such as CBT (cognitive behavioral therapy), achieves better long-term outcomes than medication alone. Both inpatient and outpatient rehab programs use these combined approaches to reduce relapse risk and address the behavioral patterns driving use.

Medical Detox for GHB Withdrawal

Given the potential for seizures, delirium, and life-threatening complications, medical detox is the appropriate starting point for anyone with significant physical dependence on GHB. GHB detox at a professional addiction treatment facility provides continuous monitoring, medication management, and the capacity to respond quickly when symptoms escalate. Unlike withdrawal from opioids, which is rarely fatal, withdrawal from GHB carries genuine mortality risk when left unmanaged, placing it in the same category of medical urgency as alcohol withdrawal.

Inpatient medical detox is particularly indicated for individuals who:

• Have been using more than 30ml of GHB daily for 2 or more weeks.

• Does GHB more than 3 times per day.

• Have previously experienced severe withdrawal, including seizures, delirium, or psychosis.

• Are already showing confusion or hallucinations at the time of assessment.

• Are withdrawing from multiple substances simultaneously.

• Have significant medical comorbidities, such as liver or kidney disease.

Like opioid withdrawal, outpatient management of GHB withdrawal is possible in planned, mild withdrawal cases, but requires a responsible support person present throughout, daily face-to-face clinical assessment for at least 5 days, and clear arrangements for emergency transfer to a hospital if symptoms worsen. If withdrawal is not controlled within the first 12 hours, transition to inpatient care is strongly recommended.

The GHB comedown from regular heavy use is a genuine medical emergency in a meaningful proportion of cases. Facilities providing medical detox use validated assessment tools, like the CIWA-Ar scale, to track clinical signs and withdrawal severity over time and adjust treatment accordingly.

After medical stabilization, the path forward involves rehabilitation programming that addresses both the physical and psychological dimensions of addiction. Inpatient and intensive outpatient programs provide structured therapeutic support, helping individuals build the skills, coping tools, and peer connections needed for sustained recovery.

FAQs

What are the symptoms of GBL withdrawal?

GBL (gamma-butyrolactone) is a chemical precursor that the body rapidly converts to GHB, so GBL withdrawal symptoms are essentially identical to GHB withdrawal. These include tremors, sweating, anxiety, nausea, elevated heart rate, insomnia, hallucinations, and potentially severe delirium and seizures. GBL is considered roughly twice as potent as GHB, so dependence may develop faster, and withdrawal can be particularly intense.

What is the antidote for GHB?

There is no specific antidote for GHB. Medical management of GHB overdose focuses on supportive care, including airway management, monitoring of vital signs, and addressing any complications. For GHB withdrawal rather than overdose, benzodiazepines are the primary pharmacological treatment used to stabilize the nervous system and prevent severe complications.

What is the characterization of GHB withdrawal syndrome?

GHB withdrawal syndrome is characterized by a cluster of symptoms that closely resembles alcohol and benzodiazepine withdrawal, reflecting GHB’s direct action on GABA receptors in the brain. It typically includes autonomic instability (rapid heart rate, elevated blood pressure, sweating), neuropsychiatric symptoms (anxiety, hallucinations, delirium, psychosis), and physical symptoms (tremors, nausea, insomnia). In a subset of patients, it progresses to severe agitated delirium requiring intensive care, and can trigger rhabdomyolysis with secondary renal failure.

Get Treatment for GHB Dependence at District Behavioral Health Group

We deliver compassionate, evidence-based treatment for gamma-hydroxybutyrate withdrawal syndrome at District Behavioral Health Group. You can get seamless care across the full continuum via our national network of treatment providers.

Our comprehensive addiction treatment programs for GHB and other drugs include:

• Medical detox – Supervised clinical detoxification and relapse prevention with FDA-approved medications and psychotherapies.

• Stabilization and crisis intervention – Continuous emotional and medical support to help those in crisis from psychoactive substances restore safety and functioning without visiting the emergency department.

• Inpatient and residential programs – 24-7 inpatient management, with structured routines, personalized therapies, and clinical support in a setting free of triggers and distractions.

• PHP (partial hospitalization programs) – Full-time outpatient programs, providing immersive therapy and robust support.

• IOP (intensive outpatient programs) – Part-time outpatient programs, offering structure and accountability while enabling you to meet your everyday commitments.

• OP – outpatient programs) ­– Ongoing outpatient treatment sessions to help your transition to independent living.

Discover more about our effective addiction treatment programs for club drugs like GHB by calling our admissions team today at 561-919-6792.

Sources

[1] https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/ghb-receptor

[2] https://pmc.ncbi.nlm.nih.gov/articles/PMC10241545/

[3] https://www.sciencedirect.com/science/article/pii/S092966461830127X

[4] https://www.cambridge.org/core/services/aop-cambridge-core/content/view/482581883919EDECE5E2C8207CD1776C/S1481803500010034a.pdf/withdrawal_from_gammahydroxybutyrate_14butanediol_and_gammabutyrolactone_a_case_report_and_systematic_review.pdf

[5] https://pubmed.ncbi.nlm.nih.gov/8614515

[6] https://sbmi.uth.edu/heroes/documents/Post-Acute-Withdrawal.pdf

[7] https://pmc.ncbi.nlm.nih.gov/articles/PMC2911496/